O. V. Vinogradova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A biochip-based method was developed to identify the BCR-ABL mutations that affect the thyrosine kinase domain and determine resistance to targeted therapy with thyrosine kinase inhibitors. The method is based on RT–PCR followed by allele-specific hybridization on a biochip with immobilized oligonucleotide probes. The biochip addresses 11 mutations, which(More)
  • 1